Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.

Floyd K, Hutubessy R, Kliiman K, Centis R, Khurieva N, Jakobowiak W, Danilovits M, Peremitin G, Keshavjee S, Migliori GB. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Eur Respir J. 2012 Jul; 40(1):133-42.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.